ArticlePharmaceutics2020

Semi-Mechanistic Pharmacokinetic Model to Guide the Dose Selection of Nimotuzumab in Patients with Autosomal Dominant Polycystic Kidney Disease.

Niurys de Castro-Suárez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.